MarketPeel
EVP R&D, Chief Medical Officer
Wed, Feb 12, 2025
Feb 12
sold $5.62m of ALKS
171,813 shares @ $32.69
Decreased holdings by -65.40%
Largest trade (out of 157)
Planned (10b5-1)Large Trade
Trade made by an officer
Executed under a pre-scheduled Rule 10b5-1 plan
Price 23% above 200-day moving average
ALKSAlkermes plc.
Health CarePharmaceuticals
1D0.00%
1W-1.49%
1M-8.62%
3M
6M
1Y

Recent insider activity at ALKS

FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback